-transparent.png){kind=logo}
Preliminary SAR studies on the side chain of a new class of antiviral nucleosides have shown that terminal substitution in the side-chain, with a halogen atom, lead to potent and highly specific anti-VZV agents.
Related Publications
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
January 2001,
Nucleosides, nucleotides & nucleic acids,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
February 2001,
Bioorganic & medicinal chemistry letters,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
September 2002,
Antiviral chemistry & chemotherapy,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
August 2005,
Bioorganic & medicinal chemistry letters,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
January 2003,
Nucleosides, nucleotides & nucleic acids,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
May 2001,
Antiviral chemistry & chemotherapy,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
December 2010,
Uirusu,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
January 2003,
Nucleosides, nucleotides & nucleic acids,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
December 2007,
The Journal of antimicrobial chemotherapy,
A Brancale, and
C McGuigan, and
G Andrei, and
R Snoeck, and
E De Clercq, and
J Balzarini
November 2004,
Antiviral chemistry & chemotherapy,
